Cases & Deals

Share

Excalibur Group acquires Merchant Ventures

April 2008

Client(s) Merlin Biosciences Limited

Jones Day advised Excalibur Group Holdings Limited, an international investment house specializing in medical sciences and an offshoot of Merlin Biosciences, in connection with its stock-for-stock acquisition of Merchant Ventures Investment Limited.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.